Open AccessMitochondrial changes in carcinogenesis as a goal of antitumor therapy (review)
Author(s) -
Т. Е. Потемина,
Э. В. Гузиков
Publication year - 2020
Publication title -
vestnik medicinskogo instituta «reaviz». reabilitaciâ, vrač i zdorovʹe/vestnik medicinskogo instituta "reaviz". reabilitaciâ, vrač i zdorovʹe
Language(s) - English
Resource type - Journals
eISSN - 2782-1579
pISSN - 2226-762X
DOI - 10.20340/vmi-rvz.2020.4.8
Subject(s) - carcinogenesis , mitochondrion , cancer research , mutation , cancer , cancer therapy , genetic enhancement , identification (biology) , bioinformatics , medicine , computational biology , biology , gene , genetics , botany
Causes and mechanisms of cancer development are currently one of the urgent problems of medicine. The main variant for today is the mutation theory. Identification of the system of gene mutations, including in mitochondria, leading to this or that type of tumors, made it possible to develop a personalized, so-called targeting, the therapy of malignant tumors.